CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 101 filers reported holding CARA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $444,000 | -38.8% | 27,533 | -30.7% | 0.00% | -40.0% |
| Q3 2019 | $726,000 | -22.0% | 39,720 | -8.2% | 0.01% | -28.6% |
| Q2 2019 | $931,000 | +7.6% | 43,247 | -2.0% | 0.01% | 0.0% |
| Q1 2019 | $865,000 | +75.1% | 44,131 | +16.0% | 0.01% | +75.0% |
| Q4 2018 | $494,000 | +88.5% | 38,033 | +247.4% | 0.00% | +100.0% |
| Q3 2018 | $262,000 | +482.2% | 10,948 | +198.0% | 0.00% | – |
| Q2 2018 | $45,000 | 0.0% | 3,674 | 0.0% | 0.00% | – |
| Q1 2018 | $45,000 | +9.8% | 3,674 | +11.1% | 0.00% | – |
| Q4 2017 | $41,000 | -6.8% | 3,308 | +4.7% | 0.00% | – |
| Q3 2017 | $44,000 | +22.2% | 3,158 | +33.4% | 0.00% | – |
| Q2 2017 | $36,000 | -62.5% | 2,368 | -54.5% | 0.00% | -100.0% |
| Q1 2017 | $96,000 | +2300.0% | 5,208 | +1125.4% | 0.00% | – |
| Q4 2016 | $4,000 | +33.3% | 425 | +41.7% | 0.00% | – |
| Q3 2016 | $3,000 | +200.0% | 300 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,304,603 | $18,617,000 | 2.04% |
| RHO CAPITAL PARTNERS INC | 1,499,058 | $21,392,000 | 1.96% |
| DAFNA Capital Management LLC | 315,000 | $4,495,000 | 0.94% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 432,178 | $6,167,000 | 0.72% |
| Altium Capital Management LP | 150,000 | $2,141,000 | 0.50% |
| Cypress Capital Management LLC (WY) | 16,743 | $239,000 | 0.18% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 674,846 | $9,630,000 | 0.18% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 73,902 | $1,055,000 | 0.16% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,000,000 | $28,540,000 | 0.12% |
| FIRST QUADRANT LLC/CA | 71,223 | $1,016,000 | 0.12% |